Styrelsemöte i CSR Sweden – det har gått 10 år sen starten, mycket har hänt…

csr-sweden-logga

SWEDISH SUMMARY: Idag hade vi styrelsemöte i CSR Sweden. Vi diskuterade bland mycket annat CSR Swedens verksamhet och dess olika evenemang och utbildningar. Det blev en intressant diskussion om, och reflektion över, de tio år som har passerat sen CSR Sweden bildades. Den generella uppfattningen om CSR var verkligen annorlunda på den tiden. Många kopplade samman CSR nästan uteslutande med välgörenhet. Idag finns en mycket tydligare koppling till affärsverksamheten. Vad tror ni CSR betyder om tio år? Vilket förändring kommer att ske inom CSR och hållbarhetsområdet fram emot 2025?

The board of CSR Sweden met earlier today for a board meeting.  In addition to common boeard meeting agenda items, e.g. finacials, review of ongoing operations, events and training sessions, we also shortly reflected upon the fact that CSR Sweden was created 10 years ago. The ”CSR issue” has really changed during this time period. Ten years ago, a lot of people still regarded CSR ”a charity thing”. Today we see a much stronger link to the core business strategies. And interesting of course is then to elaborate upon where CSR and sustainability will be in ten years, let’s say 2025. I promise to come back with some of my thoughts on that theme during fall – but first, please give me your ideas on ”CSR in 2025″.

Miljödiskussioner med Estlands läkemedelsverk

SWEDISH SUMMARY: Jag har idag haft intressanta diskussioner gällande läkemedel i miljön, med representanter från Estlands läkemedelsverk i samband med deras besök på Läkemedelsverket. En enkel slutsats från dagens diskussion är att den generella medvetenheten och förståelsen i samhället om hälso- och sjukvårdens samt läkemedelssektorns miljöfrågeställningar är större på vår sida av Östersjön.

 I have today met with representatives of Estonia’s MPA (Medical Products Agency) to discuss pharmaceuticals in the enviroment (PiE). The Estonian MPA has been on a three day visit to Sweden, hosted by Swedish MPA, to discuss environmental issues with a range of Swedish stakeholders, e.g. EPA and MPA, Ministry of Environment, Stockholm County Council, Akademiska hospital in Uppsala, and the industry. I gave them the perspectives of the industry on pharmaceuticals in the environment, with examples of initiatives from both the Swedish pharmaceutical association LIF, and the European association EFPIA.

Examples of LIF initiatives are the environmental classification of pharmaceutical substances on Fass.se, and the development of an environmental assessment model for pharmaceutical products. The EFPIA initiative presented was the EcoPharmacoStewardship initiative (EPS).

It was obvious from the discussions that the general awareness in society of PiE and other environmentally related issues within healthcare and the pharmaceutical sector are more common in Sweden than in Estonia. However, the interest from the Estonian visitors was great, and their personal knowledge impressive, hence and I look forward to meeting them again and take the discussions further.

Tillbaka på jobbet igen – dags att ta tag i höstens CSR och miljöutmaningar…

SWEDISH SUMMARY: Nu är jag tillbaka på kontoret igen. Dags att ta tag i höstens CSR- och miljöutmaningar. En av de viktigaste händelserna under hösten är den workshop som anordnas av EU (DG Environment) den 11 september gällande framtagandet av en EU-strategi för läkemedel i miljön men mer specifikt den så kallade BIO-IS-rapporten.

I am back in the office again after a very good and relaxing summer vacation. It is now time to start working with this autumn’s all CSR and environmental tasks. One of the most imortant and interesting events that will come is the Sept 11 EU workshop (arranged by DG Environment) on the development of a EU Strategy on PiE (Pharmaceuticals in the Environment), but more specifically on the so called BIO-IS-report. A lot of the my work, especially in my EFPIA role, the coming month (and most likely afterwards as well) will be related to that event.

Debattartikel om gröna läkemedel

SWEDISH SUMMARY: Nu har jag en vecka kvar av semestern – sen är jag tillbaka på jobbet. I väntan på blogguppdateringar kan jag rekommendera er att läsa den debattartikel om gröna läkemedel som jag i min LIF-roll skrev tillsammans med skånska regionpolitiker och LIF:s VD Anders Blanck innan semestern.

I have now one more week of vacation before coming back to the office. In the meantime – if you are eager to read new blogposts on pharmaceuticals and sustainability matters – please read the debate article on green pharmaceuticals I wrote in my LIF role together with LIF’s managing director Anders Blanck and two politicians from Region Skåne, just before we went on vacation.

See you in  a week!

Almedalen 2014 – ett par seminarier om läkemedel i miljön

Almedalen 2014

Almedalen 2014

SWEDISH SUMMARY: Nu har jag varit i Almedalen i två dagar. Som alltid en enormt hektiskt, spännande och kul upplevelse. I år är politikerveckan i Almedalen större än någonsin: Över 3000 olika seminarier och över 20000 besökare. Jag har föreläst och deltagit i panelen i två seminarier som har avhandlat läkemedel i miljön.

I have now been at the political gathering in Almedalen for two days. It is as always a fascinating experience. Over 3000 differrent seminars with more than 20000 visitors. I have given lectures and participated in panel discussions at two Pharmaceuticals in the Environment seminars.

Yesterday (Monday June 30 ) I gave a general description of the challenges with pharmaceuticals in the environment (PiE) at a seminar arranged by SIWI/Swedish Water House.

PiE-discussion with SIWI

PiE-discussion with SIWI

I also had the task to present different solutions to the challenges, especially of course the proposals from industry. I gave a short presentation of EFPIA’s (the European Federation of Pharmaceutical Industries and Associations) initiative EcoPharmacoStewardship. I also gave a brief introduction to the environmental assessment model for pharmaceutical products that has been developed by LIF (the Research-based Pharmaceutical Industry in Sweden) with me as the project manager and in close collaboration with all relevant stakeholders. Read more about the assessment model in my blog post from June 20 last year when we submitted the model proposal to the Ministry of Health and Social Affairs.

And today (Tuesday July 1) I have been part of an interesting discussion with academia and regulators on PiE. The seminar was part of a series of seminars focusing environmental challenges for the Baltic Sea. The series of seminars is arranged by Hållbara Hav (”Sustainable Sea”) and discusses potential chemical risks in an apartment (the kitchen, the bath room, and in the play room).

Hållbara Hav

Hållbara Hav

The Pharmaceuticals in the Environment (PiE) part of the discussion was introduced by Jerker Fick from MistraPharma.

Jerker Fick gives an introduction

Jerker Fick gives an introduction

Good and interesting discussions as always, and the discussion ended with all panelists giving a request/message to the politicians that will conclude the series of seminars on Wednesday (tomorrow). My message to them was that they have to understand that well documented, well controlled, and ”green pharmaceuticals” may cost a little bit more than products without solid documentation. We welcome sustainability requirements, but then public procurers need to understand that it is reasonable to pay ”a green premium”. You’ll always get what you pay for….

Now I need to go – more seminars to listen to! Almedalen has so many good seminars and meetings – it is great fun!